Stockscreener 앱 받기
2.66
2.31%
0.06
시간 외 거래:
2.64
-0.02
-0.75%
전일 마감가:
$2.60
열려 있는:
$2.61
하루 거래량:
255.08K
Relative Volume:
1.04
시가총액:
$60.51M
수익:
-
순이익/손실:
$-55.99M
주가수익비율:
-1.0634
EPS:
-2.5013
순현금흐름:
$-47.60M
1주 성능:
-5.34%
1개월 성능:
-9.52%
6개월 성능:
+135.40%
1년 성능:
+135.40%
1일 변동 폭
$2.59
$2.67
1주일 범위
$2.59
$2.93
52주 변동 폭
$0.9612
$3.1636
Boundless Bio Inc Stock (BOLD) Company Profile
명칭
Boundless Bio Inc
전화
(858) 766-9912
주소
10955 ALEXANDRIA WAY, SAN DIEGO
Compare BOLD vs VRTX, REGN, MRNA, ARGX, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BOLD
Boundless Bio Inc
|
2.66 | 60.51M | 0 | -55.99M | -47.60M | -2.5013 |
VRTX
Vertex Pharmaceuticals Inc
|
526.19 | 133.37B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
788.04 | 81.13B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
198.88 | 79.40B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
959.49 | 60.03B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
204.97 | 43.93B | 742.00K | -1.37B | -1.07B | -7.0731 |
Boundless Bio Inc Stock (BOLD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-02 | 개시 | H.C. Wainwright | Buy |
| 2025-05-28 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2024-12-13 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2024-04-22 | 개시 | Guggenheim | Buy |
| 2024-04-22 | 개시 | Leerink Partners | Outperform |
| 2024-04-22 | 개시 | Piper Sandler | Overweight |
모두보기
Boundless Bio Inc 주식(BOLD)의 최신 뉴스
Boundless Bio Inc. Share PriceBOLD, RNS News, Articles, Quotes, & Charts (NASDAQ:BOLD) - Proactive financial news
Serapha Bio Appoints Kenneth T. Mills as Chief Executive Officer and Names Senior Leadership Team to Advance Potential Best-in-Class in vivo Base Editing Program for Alpha-1 Antitrypsin Deficiency - manilatimes.net
Why Did BOLD, BLZE, QNT Stocks Surge To 52-Week Highs Today - stocktwits.com
TANG KEVIN C Trims Boundless Bio Inc (BOLD) Stake Amid Volatile Trading - GuruFocus
Boundless Bio (BOLD) Q2 2026 Earnings: Wider-than-Expected Loss of $1.06 per Share Pressures the Stock - dars.gov.et
BOLD Q2 2026 Earnings: Wider-than-Expected $1.06 Per Share Loss Reflects Clinical-Stage InvestmentEPS Revision Trend - careplusvn.com
Boundless Bio (NASDAQ: BOLD) Updates Serapha Merger with 19.99% Ownership Cap and Revised Voting Rules - kalkinemedia.com
Boundless Bio Amends Merger Agreement with Serapha Bio - TipRanks
Boundless Bio (NASDAQ: BOLD) adds $0.00001 warrants to cap ownership in Serapha deal - Stock Titan
Kevin Tang group trims Boundless Bio (BOLD) stake, returns profit - Stock Titan
2,426,857 Boundless Bio (NASDAQ: BOLD) shares held by Zachary Hornby - stocktitan.net
Boundless (BOLD) Results Check: EPS Falls Short of Its Estimate; Investor Response: The Stock Ends Down 1.33% in the Latest ReadingEarnings Miss Streak - dars.gov.et
Boundless (BOLD) Financial Update: Profit Per Share Falls Below Its Benchmark in the Reported Period - careplusvn.com
Boundless (BOLD) Session: Climbs 1.40% to $2.90 in the Current Update; Trading Range: Price Remains Between $2.75 Support and $3.04 Resistance on the DayFactor Timing - vinanet.vn
Boundless (BOLD) Results Versus Estimates: Profit Per Share Falls Below Its Benchmark in the Available Record; Shares Show Limited Movement under the Current SnapshotFiscal Year Earnings - vinanet.vn
Boundless Bio (BOLD): ADAR1 Capital discloses 8.8% beneficial ownership stake - Stock Titan
Boundless Bio (BOLD): Citadel entities and Ken Griffin report 0.6% ownership - Stock Titan
Boundless Bio (BOLD) Edges Up to $2.79 as Stock Holds Tight Trading RangeTriple Bottom - Vinanet
Boundless Bio, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Boundless Bio Inc (BOLD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Boundless Bio, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Boundless Bio, Inc. 2Q 2026: Net loss $23.7M, EPS $(1.06) — 10-Q Summary - TradingView
Boundless Bio (Nasdaq: BOLD) plans Serapha merger and dividend - Stock Titan
Boundless Bio (BOLD) Advances 3.57% to $2.90 as Support at $2.75 HoldsBreakout Confirmation - careplusvn.com
Boundless Bio, Inc. Revenue Breakdown – NASDAQ:BOLD - TradingView
Boundless Bio Inc expected to post a loss of 58 cents a shareEarnings Preview - TradingView
Boundless Bio Inc (BOLD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Boundless Bio Inc (BOLD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
BOLD|Boundless Bio Inc|Price:2.485|Chg%:-0.085 - TradingKey
Boundless Bio Inc (BOLD) Valuation: PE, PB & Fair Value Analysis - TradingKey
Boundless Bio Inc (BOLD) Institutional Confidence - TradingKey
Boundless Bio Inc (BOLD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Boundless Bio Inc (BOLD) Balance Sheet - tradingkey.com
BOLD|Boundless Bio Inc|Price:2.580|Chg%:+0.010 - TradingKey
TradingKey - TradingKey
Boundless Bio Inc (BOLD) Income Statement - TradingKey
Boundless Bio Inc (BOLD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Boundless Bio director Kevin Tang buys $11,865 in shares By Investing.com - Investing.com South Africa
Major Investor Quietly Boosts Stake in Emerging Biotech Player - TipRanks
Form 4 Boundless Bio Inc For: 21 July By Investing.com - Investing.com South Africa
Boundless Bio 10% owner Kevin Tang acquires $11,876 in common shares - Bitget
Boundless Bio director Kevin Tang buys $11,865 in shares - Investing.com
Boundless Bio (NASDAQ: BOLD) major Tang Capital holder adds 4,863 shares - Stock Titan
BOLD Q1 2026 Earnings: EPS Miss as Pre-Revenue Biotech Focuses on Pipeline ProgressMargin Expansion Trends - careplusvn.com
Boundless Bio (BOLD) Holds Steady Near Resistance: Key Levels in FocusVirgin POC - careplusvn.com
Boundless Bio Inc. (BOLD) Holds Near Support After Modest DeclineBuyback Factor - dars.gov.et
Tang Capital’s Kevin Tang reports $154,586 Boundless Bio common share purchase - Bitget
Boundless Bio: ten percent owner Kevin Tang buys $155,645 By Investing.com - Investing.com South Africa
Boundless Bio: ten percent owner Kevin Tang buys $155,645 - Investing.com
63,969 shares bought by Tang Capital in Boundless Bio, Inc. (BOLD) - Stock Titan
Form 4 Boundless Bio Inc For: 13 July By Investing.com - Investing.com Nigeria
Boundless Bio Inc (BOLD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.06%
2.55%
자본화:
|
볼륨(24시간):